LCTX

LINEAGE CELL THERAPEUTICS INC

Healthcare | Micro Cap

-$0.02

EPS Forecast

$2.2

Revenue Forecast

Announcing earnings for the quarter ending 2026-09-30 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.02

Revenue Forecast:

$2.2

EPS Surprise Forecast:

-$0.003

Revenue Surprise Forecast:

-$1

Post-release price volatility - High

Post-release Overnight Move:

±8.1%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

45%

Probability of beating revenue consensus:

34%

Probability of beating both EPS & revs consensus:

21%

Probability of missing both EPS & revs consensus:

42%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-3

Beta (β)

Forward Looking Beta (β):

1.20

Earnings volatility

EPS standard deviation:

$0.04

Revenue standard deviation:

$7

As % of share price:

3.47% EXTREME UNCERTAINTY

As % of market cap:

2.64% HIGH

Confidence intervals and percentiles

EPS 95th %ile:

$0.02

Revenue 95th %ile:

$10

EPS 75th %ile:

-$0.01

Revenue 75th %ile:

$4

EPS 25th %ile:

-$0.03

Revenue 25th %ile:

$0

EPS 5th %ile:

-$0.07

Revenue 5th %ile:

-$5

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

38% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

51% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$220

Bid-ask per Share:

$0.02